Recordati Industria Chimica e Farmaceutica S.p.A. (LON:0KBS)
54.33
+0.93 (1.73%)
At close: Jul 1, 2025
LON:0KBS Revenue
Recordati Industria Chimica e Farmaceutica had revenue of 679.96M EUR in the quarter ending March 31, 2025, with 11.87% growth. This brings the company's revenue in the last twelve months to 2.41B, up 12.85% year-over-year. In the year 2024, Recordati Industria Chimica e Farmaceutica had annual revenue of 2.34B with 12.45% growth.
Revenue (ttm)
2.41B EUR
Revenue Growth
+12.85%
P/S Ratio
4.72
Revenue / Employee
526.66K EUR
Employees
4,583
Market Cap
9.53B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.34B | 259.23M | 12.45% |
Dec 31, 2023 | 2.08B | 229.02M | 12.36% |
Dec 31, 2022 | 1.85B | 273.23M | 17.29% |
Dec 31, 2021 | 1.58B | 131.21M | 9.06% |
Dec 31, 2020 | 1.45B | -32.98M | -2.23% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
HSBC Holdings | 44.89B |
Shell | 217.54B |
Unilever | 50.25B |
Rolls-Royce Holdings | 18.91B |
British American Tobacco p.l.c. | 25.87B |
Rio Tinto Group | 42.86B |
RELX PLC | 9.43B |